基于T细胞的癌症免疫疗法的进展:从基本机制到临床前景
Kaili Zhang1, Yi Zhang1, Pan Xiang1
1Department of Molecular Pharmacology, Tianjin Medical University Cancer Institute and Hospital; National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Molecular pharmaceutics
|May 13, 2025
概括
尽管与年龄相关的免疫力下降,但T细胞疗法对癌症治疗有希望. 新的查技术正在加速发现瘤抗原,并改善T细胞受体疗法,以获得更好的患者结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- T细胞和T细胞受体 (TCRs) 对抗癌症的适应性免疫至关重要.
- 免疫衰老,或与年龄相关的免疫衰退,损害了身体对抗瘤的能力.
- 在T细胞生物学和查技术的进步正在推动癌症免疫治疗的进步.
研究的目的:
- 审查T细胞成熟,抗瘤反应,以及衰老对T细胞多样性的影响.
- 讨论当前和新兴的基于T细胞的癌症疗法.
- 为突出新的查技术TCR抗原相互作用.
主要方法:
- 关于T细胞生物学和免疫发生的综合性审查.
- 对收养T细胞疗法 (TIL,TCR-T,CAR-T) 的最新进展进行分析.
- 检查DNA编码的图书馆技术用于高通量选.
主要成果:
- 基于T细胞的疗法正在迅速发展,随着对T细胞功能的更好理解.
- 新的查技术正在增强发现瘤抗原和TCR亲和力的能力.
- 正在制定战略,以克服瘤微环境的挑战.
结论:
- T细胞疗法为持久的癌症治疗提供了显著的潜力.
- 查技术的进步对于优化TCR-T疗法至关重要.
- 进一步的研究有望将T细胞免疫疗法的益处扩展到更多患者.
相关概念视频
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Cancer Vaccines
278
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
278
Cytotoxic T Cells-mediated Immune Response
740
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
740
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
T Cell Activation and Clonal Selection
550
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
550
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


